Thousands of men with prostate cancer could avoid invasive treatment and side-effects after scientists developed a personalised tool to give them a prognosis.
Every year more than 47,000 men in the UK are diagnosed with the disease.
But in many cases, it is not clear how fast-growing the cancer is.
Currently, around half of patients are classed as low or intermediate risk – and left to decide if they should opt for treatment such as surgery and radiotherapy, or could safely opt to be monitored.
Treatment can carry significant side-effects, including urinary incontinence and erectile dysfunction.
Rates of treatment for cases classed as low-risk vary more than ten-fold between different hospitals,…